Jump to content

Percutaneous ethanol injection

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Dcirovic (talk | contribs) at 21:56, 27 May 2016 (clean up using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Percutaneous ethanol injection is a possible treatment for hepatocellular carcinoma.[1]

Also used for thyroid and parathyroid disease.[2]

Instead of removing unwanted tissue surgically it is killed with alcohol.

It is similar in mechanism to Alcohol septal ablation for heart problems.

See also

References

  1. ^ Shiina S, Tateishi R, Imamura M, et al. (October 2012). "Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors". Liver International. 32 (9): 1434–42. doi:10.1111/j.1478-3231.2012.02838.x. PMC 3466412. PMID 22712520.
  2. ^ Bennedbaek FN, Karstrup S, Hegedüs L (March 1997). "Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases". European Journal of Endocrinology. 136 (3): 240–50. doi:10.1530/eje.0.1360240. PMID 9100545.


Stub icon

This medical treatment–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Percutaneous_ethanol_injection&oldid=722403579"